Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
27.4M
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
12.7M
-
Shares change
-
+1.35M
-
Total reported value, excl. options
-
$269M
-
Value change
-
+$30.9M
-
Number of buys
-
38
-
Number of sells
-
-42
-
Price
-
$21.22
Significant Holders of ICAD, INC. - Common Stock, $0.01 par value (ICAD) as of Q1 2021
100 filings reported holding ICAD - ICAD, INC. - Common Stock, $0.01 par value as of Q1 2021.
ICAD, INC. - Common Stock, $0.01 par value (ICAD) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.7M shares
of 27.4M outstanding shares and own 46.3% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.4M shares), VANGUARD GROUP INC (1.14M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (928K shares), Portolan Capital Management, LLC (892K shares), G2 Investment Partners Management LLC (747K shares), FEDERATED HERMES, INC. (707K shares), Parkman Healthcare Partners LLC (648K shares), WELLINGTON MANAGEMENT GROUP LLP (430K shares), PURA VIDA INVESTMENTS, LLC (388K shares), and GEODE CAPITAL MANAGEMENT, LLC (343K shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.